| scholarly article | Q13442814 |
| P50 | author | Yoshifumi Kasuga | Q90009750 |
| Yuji Nishiwaki | Q90049135 | ||
| P2093 | author name string | Masaya Nakamura | |
| Morio Matsumoto | |||
| Mamoru Tanaka | |||
| Kana Miyamoto | |||
| Takeshi Miyamoto | |||
| Yuiko Sato | |||
| Kei Miyakoshi | |||
| Satoru Ikenoue | |||
| P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
| Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 | ||
| The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Osteoporosis with vertebral fractures associated with pregnancy: two case reports | Q34230332 | ||
| Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients | Q34346682 | ||
| Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts | Q34679499 | ||
| A case series of pregnancy- and lactation-associated osteoporosis and a review of the literature | Q36052334 | ||
| Serum 25-OHD insufficiency as a risk factor for hip fracture | Q36796942 | ||
| HIF1α is required for osteoclast activation by estrogen deficiency in postmenopausal osteoporosis | Q37236532 | ||
| Mechanical loading, estrogen deficiency, and the coupling of bone formation to bone resorption | Q37296036 | ||
| Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. | Q38248243 | ||
| Presentation and management of osteoporosis presenting in association with pregnancy or lactation | Q38457933 | ||
| Regulation of Bone Metabolism by Sex Steroids | Q38657323 | ||
| Vitamin D Deficiency with High Intact PTH Levels is More Common in Younger than in Older Women: A Study of Women Aged 39-64 Years | Q38911109 | ||
| The Skeleton Is a Storehouse of Mineral That Is Plundered During Lactation and (Fully?) Replenished Afterwards | Q38972532 | ||
| Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study | Q39891613 | ||
| A Role for the Calcitonin Receptor to Limit Bone Loss During Lactation in Female Mice by Inhibiting Osteocytic Osteolysis. | Q40775024 | ||
| Occult vitamin D deficiency in postmenopausal US women with acute hip fracture | Q40814972 | ||
| Prevention of hip fractures: risk factor modification | Q40883652 | ||
| Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation | Q41668487 | ||
| Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial | Q46110515 | ||
| Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. | Q47891510 | ||
| Vitamin D content in human breast milk: a 9-mo follow-up study | Q47938810 | ||
| Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis | Q48516953 | ||
| A serum metabolomics-based profile in low bone mineral density postmenopausal women. | Q51003813 | ||
| Bone mineral density measurement in puerperal women as a predictor of persistent osteopenia. | Q51660684 | ||
| Vitamin D plasma concentrations in pregnant women and their preterm newborns | Q57801488 | ||
| Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation1 | Q59644217 | ||
| Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis | Q60698981 | ||
| Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis | Q71644718 | ||
| Longitudinal changes in bone mineral density during normal pregnancy | Q73255864 | ||
| The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats | Q73826959 | ||
| Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation | Q74411385 | ||
| Lumbar bone mineral density changes during pregnancy and lactation | Q78171570 | ||
| Vitamin D and intact PTH status in patients with hip fracture | Q80014807 | ||
| Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study | Q84183889 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6787 | |
| P577 | publication date | 2019-05-13 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Changes in bone metabolic profile associated with pregnancy or lactation | |
| P478 | volume | 9 |
| Q92707901 | Association between breastfeeding and osteoporotic hip fracture in women: a dose-response meta-analysis | cites work | P2860 |
Search more.